Results 11 to 20 of about 145,724 (263)

Immunomodulation of Myocardial Fibrosis

JACC: Basic to Translational Science, 2023
Immunotherapy is a potential cornerstone in the treatment of myocardial fibrosis. During a myocardial insult or heart failure, danger signals stimulate innate immune cells to produce chemokines and profibrotic cytokines, which initiate self-escalating inflammatory processes by attracting and stimulating adaptive immune cells. Stimulation of fibroblasts
Sikking, Maurits A., Stroeks, Sophie L.VM., Marelli-Berg, Federica, Heymans, Stephane R.B., Ludewig, Burkhard, Verdonschot, Job A.J.   +5 more
openaire   +4 more sources

Myocardial fibrosis [PDF]

Tidsskrift for Den norske legeforening, 2018
Myokardfibrose oppstår sekundært til kardial belastning eller skade. I denne oversiktsartikkelen presenteres sentrale aspekter ved myokardfibrose.Vi foretok 2 søk i PubMed som til sammen ga 417 treff. Artiklenes relevans ble vurdert på grunnlag av tittel, sammendrag og eventuell fulltekst. 44 sentrale artikler ble inkludert.Myokardfibrose klassifiseres
Torvald, Espeland, Ida Gjervold, Lunde, Brage, H Amundsen, Lars, Gullestad, Svend, Aakhus   +4 more
openaire   +2 more sources

Hypertensive myocardial fibrosis [PDF]

Nephrology Dialysis Transplantation, 2005
A variety of cardiac structural and functional changes, such as increased left ventricular mass (LVM), left atrial and aortic root enlargement, LV dysfunction, impairment of coronary reserve and prolonged ven- tricular repolarization, have been described in patients with long-standing arterial hypertension [1,2].
CUSPIDI, CESARE, Ciulla, M, Zanchetti, A.   +2 more
openaire   +5 more sources

Myocardial Fibrosis in Athletes [PDF]

Mayo Clinic Proceedings, 2016
Myocardial fibrosis (MF) is a common phenomenon in the late stages of diverse cardiac diseases and is a predictive factor for sudden cardiac death. Myocardial fibrosis detected by magnetic resonance imaging has also been reported in athletes. Regular exercise improves cardiovascular health, but there may be a limit of benefit in the exercise dose ...
van de Schoor, Freek R., Aengevaeren, Vincent L., Hopman, Maria T.E., Oxborough, David L., George, Keith P., Thompson, Paul D., Eijsvogels, Thijs M.H.   +6 more
openaire   +3 more sources

Evaluation of myocardial fibrosis by cardiac magnetic resonance imaging in patient with myotonic dystrophy type 1 [PDF]

Zhenduanxue lilun yu shijian, 2021
Objective: To evaluate myocardial fibrosis by cardiac magnetic resonance (CMR) in the patients with myo-tonic dystrophy type 1 (DM1), and compare the value of CMR and ECG.
HUANG Shaohua, LIANG Zonghui, TONG Huan, GUAN Xueni, GUO Ying, ZHANG Yan, CAO Bin, SUN Yumin
doaj   +1 more source

Multifunctional biomaterial platforms for blocking the fibrosis process and promoting cellular restoring effects in myocardial fibrosis therapy

Frontiers in Bioengineering and Biotechnology, 2022
Myocardial fibrosis is the result of abnormal healing after acute and chronic myocardial damage and is a direct cause of heart failure and cardiac insufficiency.
Tian Yue, Tian Yue, Shiqiang Xiong, Dezhi Zheng, Yi Wang, Pan Long, Jiali Yang, Jiali Yang, Dunzhu Danzeng, Han Gao, Xudong Wen, Xin Li, Jun Hou, Jun Hou   +13 more
doaj   +1 more source

Myocardial fibrosis — a new component of heart remodeling in athletes?

Кардиоваскулярная терапия и профилактика, 2019
Studies on the myocardial fibrosis are a new direction in sports medicine. Much data indicate the formation of myocardial hypertrophy, as a natural myocardial response to systematic physical activity, while the fibrosis development in this category of ...
A. S. Sharykin, V. A. Badtieva, I. I. Trunina, I. M. Osmanov   +3 more
doaj   +1 more source

Myocardial Fibrosis in the Pathogenesis, Diagnosis, and Treatment of Hypertrophic Cardiomyopathy

Cardiovascular Innovations and Applications, 2021
Hypertrophic cardiomyopathy (HCM) is a type of hereditary cardiomyopathy caused by gene mutation. Its histological features include cardiomyocyte hypertrophy and disarray as well as myocardial fibrosis.
Zeyi Cheng, Miaomiao Qi, Chengyuan Zhang, Yanxia Mao   +3 more
doaj   +1 more source

Biomarkers in patients with myocardial fibrosis

Open Life Sciences, 2017
Myocardial fibrosis is observed in many cardiovascular diseases including hypertension, heart failure and cardiomyopathy. Myocardial fibrosis has been proved to be reversible and treatable only under timely intervention, which makes early detection and ...
An Zhe, Yang Guang, Zheng Haikuo, Nie Wei, Liu Guohui   +4 more
doaj   +1 more source

DIAGNOSTIC METHODS FOR MYOCARDIAL FIBROSIS

Измерение, мониторинг, управление, контроль, 2023
Background. Myocardial fibrosis is a global public health problem because it is associated with almost all forms of cardiovascular diseases. Timely detection of myocardial fibrosis is an urgent task contributing to improving the quality of patients' life
Natalia A. Serzhantova
doaj   +1 more source